Abstract: A gateway processor coordinates communication among an autonomous vehicle components boundary domain, a vehicle boundary domain, and an oversight server. The gateway processor receives a message from the oversight server. The gateway processor determines a priority level, a domain tag data, and destination data associated with the message. The priority level indicates a scheduling requirement associated with the message. The domain tag data indicates that the message is associated with a particular domain from among the autonomous vehicle components boundary domain, the vehicle components boundary domain, or the security domain. The destination data indicates that the message is designated to a particular component within the particular domain. In response, the gateway processor schedules the message to be transmitted to the particular domain. The gateway processor routes the message to the particular component.

Abstract: A semiconductor structure is disclosed. In one example, the semiconductor structure includes: a device region having at least one semiconductor device; a dummy region in contact with the device region; and at least one thermal conductor embedded in the dummy region.

Abstract: Techniques associated with detecting non-deterministic behavior with a component and/or subcomponents of an autonomous vehicle are discussed herein. In some cases, a simulation system may be configured to simulate operations of the autonomous vehicle and to detect changes in behavior between instances and with respect to log data or expected results. The simulation system may flag or otherwise identify components and/or subcomponents responsive to detecting potentially non-deterministic behavior.

Abstract: Embodiments of the present disclosure provide a semiconductor package. In one embodiment, the semiconductor package includes a first integrated circuit die having a first circuit design, and the first integrated circuit die comprises a first device layer and a first interconnect structure. The semiconductor package also includes a second integrated circuit die having a second circuit design different than the first circuit design, and the second integrated circuit die comprises a second device layer and a second interconnect structure having a first side in contact with the first device layer and a second side in direct contact with the first interconnect structure of the first integrated circuit die. The semiconductor package further includes a substrate having a first side bonded to the first interconnect structure, wherein the second integrated circuit die is surrounded by at least a portion of the substrate.

Abstract: Embodiments of the present disclosure provide a semiconductor package comprising a first integrated circuit (IC) die having a first back-end-of-the-line (BEOL) structure, a second integrated circuit die having a second BEOL structure, an integrated BEOL structure having a first side in direct contact with both the first BEOL structure and the second BEOL structure. In some embodiments, a substrate is further disposed at a second side of the integrated BEOL structure to support both the first integrated circuit die and the second integrated circuit die.

Abstract: The invention provides compositions and methods for providing a cardioprotective effect in a subject. Specifically, the invention relates to compositions and methods for treating cardiovascular ailments, such as compositions and methods for attenuating or ameliorating the development of cardiac contractile dysfunction, myocardial fibrosis or maladaptive remodeling in a subject having or having had a myocardial infarction (MI) or at risk of having a myocardial infarction by administering a retinoic acid receptor-beta (RAR?) agonist.

Abstract: The present disclosure relates to a technical field of optical lenses, and discloses a camera optical lens. The camera optical lens includes seven lenses. An order of the seven lenses is sequentially from an object side to an image side, which is shown as follows: a first lens having a negative refractive power, a second lens having a positive refractive power, a third lens having a positive refractive power, a fourth lens having a negative refractive power, a fifth lens having a refractive power, a sixth lens having a positive refractive power, and a seventh lens having a negative refractive power. While the camera optical lens has good optical performance, the camera optical lens further meets design requirements of large aperture, wide-angle, and ultra-thinness.

Abstract: This invention relates to pharmaceutical compositions and methods for treating (including managing) or preventing metabolic syndrome related conditions using one or more RAR? (e.g., RAR?2) agonists. Such conditions include, but are not limited to, diseases in pancreas, liver, kidney, testes, muscle, or adipose tissue, as well as other organs that are associated with high fat diet and/or vitamin A deficiency, as well as other conditions associated with abnormal level of triglyceride, cholesterol and/or glucose.

Abstract: The invention provides compositions and methods for providing a cardioprotective effect in a subject. Specifically, the invention provides compositions and methods for treating cardiovascular ailments, for example, ischemia/reperfusion (I/R) injury, cardiac arrhythmias, oxidative stress, or cardiac failure by administering a retinoic acid receptor-beta (RAR?) agonist.

Abstract: A semiconductor device includes: a first conductive structure that comprises a first portion having sidewalls and a bottom surface, wherein the first conductive structure is embedded in a first dielectric layer; and an isolation layer comprising a first portion and a second portion, wherein the first portion of the isolation layer lines the sidewalls of the first portion of the first conductive structure, and the second portion of the isolation layer lines at least a portion of the bottom surface of the first portion of the first conductive structure.

Abstract: This invention relates to pharmaceutical composition and methods of using vitamin A and/or RAR? agonist for the treatment or prevention of diseases or conditions associated with high fat diet and/or vitamin deficiency.

Abstract: The invention provides compositions and methods for providing a cardioprotective effect in a subject. Specifically, the invention provides compositions and methods for treating cardiovascular ailments, for example, ischemia/reperfusion (I/R) injury, cardiac arrhythmias, oxidative stress, or cardiac failure by administering a retinoic acid receptor-beta (RAR?) agonist.

Abstract: This invention relates to pharmaceutical compositions and methods for treating (including managing) or preventing metabolic syndrome related conditions using one or more RAR e.g., RAR agonists. Such conditions include, but are not limited to, diseases in pancreas, liver, kidney, testes, muscle, or adipose tissue, as well as other organs that are associated with high fat diet and/or vitamin A deficiency, as well as other conditions associated with abnormal level of triglyceride, cholesterol and/or glucose.

Abstract: A scanner comprises a mirror, a first piezoelectric actuator, a second piezoelectric actuator, a third piezoelectric actuator, a fourth piezoelectric actuator, a first connecting member, a second connecting member, a first mirror spring, a second mirror spring, a stationary member, a first plurality of actuator springs, a second plurality of actuator springs, a third plurality of actuator springs, a fourth plurality of actuator springs, a first plurality of electrodes, and a second plurality of electrodes. The scanner is driven by piezoelectric actuators. A method of fabricating the scanner comprises the steps of providing a wafer; oxidation; deposition; patterning; and applying a singulation process.

Abstract: A vehicle includes one or more controllers, programmed to responsive to detecting a mismatch between a biometric information of a user collected via a biometric sensor and a biometric record, send a lockup signal to a mobile device enrolled with the vehicle to lock an application; and responsive to successfully performing an authentication through an interaction with the application in a lockup mode, send an unlock signal to the mobile device to unlock the application.

Abstract: A semiconductor structure is disclosed. In one example, the semiconductor structure includes: a device region having at least one semiconductor device; a dummy region in contact with the device region; and at least one thermal conductor embedded in the dummy region.

Abstract: A semiconductor structure is disclosed. In one example, the semiconductor structure includes: a device region having at least one semiconductor device; a dummy region in contact with the device region; and at least one thermal conductor embedded in the dummy region.

Abstract: A medical implant has a center axis and includes first and second flexible waved strands disposed around the center axis. The second flexible waved strand is in spatial communication with the first flexible waved strand to form a plurality of first unit shapes and a plurality of second unit shapes. Therein, the first unit shapes and the second unit shapes are staggered around the center axis. The first unit shapes are coupled to the second unit shapes to cause the first and second flexible waved strands to move substantially along the center axis. The first and second flexible waved strands together define a self-anchoring configuration in a radial direction perpendicular to the center axis so that a ratio of a von Mises stress to an axial displacement of the medical implant during an implant compression of the medical implant is greater than 0.1 and less than 30.

Abstract: A vehicle includes one or more controllers, programmed to responsive to detecting a mismatch between a biometric information of a user collected via a biometric sensor and a biometric record, send a lockup signal to a mobile device enrolled with the vehicle to lock an application; and responsive to successfully performing an authentication through an interaction with the application in a lockup mode, send an unlock signal to the mobile device to unlock the application.

Abstract: A scanner comprises a mirror, a first and second springs, an insulation layer and a first and second piezoelectric elements. The insulation layer is directly attached to the mirror and the first and second springs. The first and second piezoelectric elements are directly attached to the insulation layer. The first piezoelectric element has a first portion above the first spring, a mid-range portion above the mirror and a second portion above the second spring. The second piezoelectric element has a first portion above the first spring, a mid-range portion above the mirror and a second portion above the second spring. The first piezoelectric element has a first upper electrode layer, a first piezoelectric layer and a first lower electrode layer. The second piezoelectric element has a second upper electrode layer, a second piezoelectric layer and a second lower electrode layer.